Profiles
Revision as of 16:46, 1 May 2017 by Jlisiecki (talk | contribs) (→Stage 1: Public Comment Profiles)
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
- QIBA PET Amyloid Profile 2017-04-28 (BC Vote to Release for Public Comment Form: )
- DWI Profile 2017-04-27 (Public Comment Form: https://goo.gl/fkL6rB)
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)